Все учереждения в списке проводят это КИ, и все набирают людей? Подробностей нет?
Добавлено через 2 минуты
Поискал на
clinicaltrials.gov/ct2/results?cond=Kidney+Cancer&term=&cntry1=NS%3ARU&st ate1=&SearchRecruiting=Find+a+study+to+participate +in&recrs=a
1
Recruiting Safety and Preliminary Efficacy of SBRT in Patients With Metastatic RCC Treated With Targeted or IO Therapy Metastatic Renal Cell Carcinoma Radiation: SBRT
2
Recruiting A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101) Renal Cell Cancer Drug: Avelumab (MSB0010718C); Drug: Axitinib (AG-013736); Drug: Sunitinib
3
Recruiting A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy Renal Cell Carcinoma Drug: Atezolizumab; Other: Placebo
4
Recruiting Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic Factors Carcinoma, Renal Cell; Clear Cell Renal Cell Carcinoma Drug: axitinib
5
Recruiting A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma. Renal Cell Carcinoma Drug: RAD001
6
Recruiting A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors Melanoma; Lung Cancer; Renal Cell Carcinoma Biological: BCD-100
7
Recruiting Study of Pembrolizumab (MK-3475) Monotherapy in Locally Advanced/Metastatic Renal Cell Carcinoma (MK-3475-427/KEYNOTE-427) Renal Cell Carcinoma Biological: Pembrolizumab
8
Recruiting Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426) Renal Cell Carcinoma Biological: Pembrolizumab; Drug: Axitinib; Drug: Sunitinib
|